Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01737528 · ClinicalTrials.gov registry record

STS/ACC Transcatheter Valve Therapy Registry (TVT Registry)

A clinical trial of Aortic Valve Stenosis, sponsored by The Society of Thoracic Surgeons.

Recruiting
Registry status
16,000
Enrollment target
1
Study location

NCT01737528: Recruiting study of Aortic Valve Stenosis, sponsored by The Society of Thoracic Surgeons.

NCT01737528 is a study of Aortic Valve Stenosis that is actively recruiting participants, run by The Society of Thoracic Surgeons. The registered enrollment target is 16,000 participants, above the 510-participant average among 30 other Aortic Valve Stenosis trials with a reported enrollment target (3037% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01737528, a study of Aortic Valve Stenosis, is actively recruiting participants, sponsored by The Society of Thoracic Surgeons.

RECRUITING
Registry status
16,000 participants
Enrollment target
1
Study location

Study Summary

The TVT Registry™ is a benchmarking tool developed to track patient safety and real-world outcomes related to the transcatheter aortic valve replacement (TAVR) procedure. Created by The Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC), the TVT Registry is designed to monitor the safety and efficacy of this new procedure for the treatment of aortic stenosis.

Primary Outcome

increase in the 30-day risk of adverse events among patients receiving TAVR

Conditions Studied

Interventions

  • PROCEDURE Transcatheter Aortic Valve Replacement

Study Locations (1)

District of Columbia

  • American College of Cardiology - Washington D.C.

Trial Details

FieldValue
Enrollment Target 16,000 participants
Start Date 2012-06
Est. Completion 2035-06
The Society of Thoracic Surgeons

1 total trials

What NCT01737528 shows while recruiting

NCT01737528 is an observational study that tracks outcomes without assigning an intervention. Its 16,000 participants enrollment target places it among the larger protocols in the corpus, above the 510-participant average among 30 other Aortic Valve Stenosis trials with a reported enrollment target (3037% higher).

The record links to 1 condition, with Aortic Valve Stenosis appearing as the primary indexed condition, and to 1 intervention - of which Transcatheter Aortic Valve Replacement is the first listed.

NCT01737528 reports a single indexed study location in District of Columbia.

Frequently Asked Questions

What is clinical trial NCT01737528 about?

NCT01737528 is a clinical study titled "STS/ACC Transcatheter Valve Therapy Registry (TVT Registry)". The TVT Registry™ is a benchmarking tool developed to track patient safety and real-world outcomes related to the transcatheter aortic valve replacement (TAVR) procedure. Created by The Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC), the TVT Registry is designed to m...

What is the current status of trial NCT01737528?

This trial is currently recruiting. The enrollment target is 16,000 participants. The study started on 2012-06. Estimated completion is 2035-06.

What conditions does trial NCT01737528 study?

This clinical trial studies the following conditions: Aortic Valve Stenosis.

What interventions are being tested in trial NCT01737528?

The interventions under investigation include: Transcatheter Aortic Valve Replacement (PROCEDURE).

Who is sponsoring clinical trial NCT01737528?

This trial is sponsored by The Society of Thoracic Surgeons, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01737528 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aortic Valve Stenosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01737528's enrollment target sits among peer trials

16,000 1st of 30 higher than 30 of 30 other Aortic Valve Stenosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Aortic Valve Stenosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06380114 · 16,000 participants · NA

    Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination

  • NCT05447806 · 15,732 participants · NA

    Diabetes Clinical Decision Support

  • NCT06951867 · 16,640 participants

    Tezspire Cardiac Events PASS

  • NCT06948838 · 16,895 participants · NA

    Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01737528, the US trial registry maintained by the National Library of Medicine. NCT01737528 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.